The use of rituximab in two children with allo-antibodies towards factor VIII.
Curry
Nikki
N
Stanworth
Simon
S
Keeling
David
D
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D019774:Blood Coagulation Factor Inhibitors / Q000037:antagonists & inhibitors; D005169:Factor VIII / Q000276:immunology*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007518:Isoantibodies / Q000097:blood*; D008297:Male; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D019774:Blood Coagulation Factor Inhibitors; D007166:Immunosuppressive Agents; D007518:Isoantibodies; D000069283:Rituximab; D005169:Factor VIII